Hypertension Drug Maker Mineralys Therapeutics Prepares for $100 million IPO

via Mdinich    Discuss    Finance
A new biopharma play is on its way as hypertension medicine developer Mineralys Therapeutics prepares to come to market.  The clinical-stage drug maker filed for ... Read More

Submit a Comment

Log in to comment or register here